This metabolite, 2-hydroxyglutaric acid, or 2-HG, has generated a tremendous amount of interest recently because it is also produced in large quantities by the mutant forms of IDH1 and IDH2 that occur in gliomas, acute myeloid leukaemias and other cancers. This evidence concerns the gene IDH2 and central nervous system cancer.